Study Focuses on Caregivers and Their Often Ignored, But Key, Role in Treating MS
A new study from France delves further into the life of multiple sclerosis (MS) caregivers and how they are perceived…
Articles by admin
MS Patient’s Pick of the Week’s News: Myelin Repair, Shape Changers, Misdiagnoses, and Virtual Reality
Here is my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Breast…
#ECTRIMS2016 – Stay Up to Date with My Pick of Congress Highlights
The show comes to town in the next week with ECTRIMS hosting what it describes as “the world’s largest…
James Received HSCT for Free, as He Lives in the UK
Virtually all the talk about availability of HSCT1 as an MS treatment includes the need to travel long distances…
MS Patient’s Pick of the Week’s News: Siponimod, Thymosin Patent, Orphan Drug, Lifestyle, and Lymphopenia Risk
Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Gilenya-like Therapy…
Taming Heat Sensitivity at 100 Degrees
Many people voiced their concerns to me about anyone with MS moving to live in a sunny climate. That worry…
Welcome or Not, FDA Focuses on Stem Cell Treatments
News that the U.S. Food and Drug Administration (FDA) is to hold a public hearing next month to…
MS Patient’s Pick of the Week’s News: Umbilical Cells, Early Drugs, REAL Research, Hemoglobin, and Fatigue
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Umbilical…
Help for Anyone Newly Diagnosed with MS
Being diagnosed with MS can be more than a bit of a shock at first. Yes, you finally know…
My Life is My Own, MS Cannot Have It
It is often said that real life mimics television, and one hit TV series certainly reflects the theme: “my life…
RebiSmart Device Seen to Improve Adherence to Therapy in RRMS Patients
People with relapsing multiple sclerosis who use a device called RebiSmart (Merck Serono) to self-inject medications like Rebif (interferon [IFN]…
MS Patient’s Pick of the Week’s News: Blood Tests, Marijuana, Cameras, and More
Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Blood Test Seen…
Delays in Seeing Specialists a Growing Barrier to MS Diagnosis and Treatment
There can be absolutely no excuse for anyone experiencing the first signs and symptoms of neurological conditions like MS…
New Pre-HSCT Treatment May Be the Future, but HSCT with Lower Dose Chemo is Right Choice for MS Patients Now
News that scientists in the U.S. are working to find a new pre-HSCT treatment to carry out stem cell…
MS Patient’s Pick of the Week’s News: Aggressive Therapies, Early MRIs, Tysabri and More
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Best First-Line…
5 Multiple Sclerosis Treatment Options
There are no specific therapies that can effectively cure patients with multiple sclerosis. However, there are a number of…
MS Patient’s Pick of the Week’s News: Antioxidant Therapies, Ocrevus, and Other Notables
Here is my Pick of the Week’s News, from articles published on Multiple Sclerosis News Today. …
Wondering How MS Will Affect Me Today
Waking up in the morning and facing the world brings a sense of wonder. Not…
Stem Cell Clinics Under Critical Scrutiny in US
Stem cell clinics are proliferating in the U.S., where there are now 570 in operation, according to a…
Phase 2 Study of Oral Antibiotic to Treat Relapsing MS, RHB-104, Nearing Finish
RedHill Biopharma announced that the final patient has completed the last step of its Phase 2 clinical study (CEASE-MS) of RHB-104 as…
MS Patient’s Pick of the Week’s News: Progressive Dwindling, Vitamin D, Disability Burdens, Talking with Doctors, and My MS Manager App
Here’s my Pick of the Week’s News, from stories published on Multiple Sclerosis News Today. Nearly…
MS Patients in US and UK Face Very Different Treatment
We may have international cooperation and worldwide this and that, but the fact remains that countries vary drastically…
There’s a Lack of Communication by Multiple Sclerosis Healthcare Providers, Study Indicates
New research from England indicates that healthcare providers do not communicate enough with their patients about the possible outcomes for their…
Remyelination Studies Abound, But How About a Workable Therapy?
Remyelination at the moment is the buzzword to beat all buzzwords in the world of research into, and treatment…
Benign MS: If Only We Had Known Then What Researchers Know Now
Now they tell me! People diagnosed with what is termed as benign MS can benefit from disease modifying drugs (DMDs),…
Nearly 75% of MS Patients in UK Study Went Through Progressive Decline Prior to Death
A new study  focused on an aspect of multiple sclerosis (MS) that is sometimes overlooked by researchers: progressive dwindling, or…
‘I am Cured,’ Says Woman with Aggressive Form of MS After Receiving HSCT in Canada
An entry in the comments section of Multiple Sclerosis News Today caught my attention a couple of weeks ago, and…
BLOG: MS Patient’s Pick of the Week’s News: Nanobionic, Recruiting, Benign, Generic Danger, and ‘Inactive but Progressive’
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Nanobionic Clothing Seen…
Action Is Needed: Costs Limit MS Patients’ Access to DMTs
A recent survey of more than 6,000Â multiple sclerosis patients in the United States found that health insurance coverage can decide…
‘My Super Diet Cured My MS! Buy My Book!’
There seems to be general agreement that achieving and keeping an overall level of good health is very important for people…